593 - Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of the Safety of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine

Saturday, October 19, 2024

2:00 PM – 2:15 PM US PT

Location: 403 B

Presenting Author(s)

Luca Tudor Giurgea, MD

Assistant Research Physician
National Institute of Allergy and Infectious Diseases
Bethesda, MD, United States

Slides

Co-Author(s)

Alison Han, MD, MS

Hospital Epidemiologist
National Institutes of Health
Bethesda, Maryland, United States
LC

Lindsay Czajkowski, MSN, NP-C

Nurse Practitioner
National Institute of Allergy and Infectious Diseases
Bethesda, Maryland, United States
HB

Holly Ann Baus, RN, MSN

Study Coordinator
National Institute of Allergy and Infectious Diseases
Bethesda, Maryland, United States
GM

Gregory Mak, MD, MPH

LID Clinical Studies Unit, Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Bethesda, Maryland, United States
KA

Kimberly Adao, RN, BSN

Study Coordinator
LID Clinical Studies Unit, Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Bethesda, Maryland, United States
IB

Ian Bellayr, PhD

Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Bethesda, Maryland, United States
AC

Adriana Cervantes-Medina, BS

Technician
National Institute of Allergy and Infectious Diseases
Bethesda, Maryland, United States
MG

Monica Gouzoulis, BS

LID Clinical Studies Unit, Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Bethesda, Maryland, United States
JS

Jenna Sherry, MS

LID Clinical Studies Unit, Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Bethesda, Maryland, United States
RA

Rani Athota, PhD

Study Coordinator
National Institute of Allergy and Infectious Diseases
Bethesda, Maryland, United States
VC

Viviane Callier, PhD

Frederick National Laboratory for Cancer Research
Bethesda, Maryland, United States
SH

Sally Hunsberger, PhD

Biostatistician/Mathematical statistician
National Institute of Allergy and Infectious Diseases
Bethesda, Maryland, United States
JP

Jaekeun Park, DVM, PhD

Department of Veterinary Medicine, VA-MD College of Veterinary Medicine, University of Maryland
College Park, Maryland, United States
JT

Jeffery Taubenberger, MD, PhD

Senior Investigator
National Institute of Allergy and Infectious Diseases
Bethesda, Maryland, United States
Matthew J. Memoli, MD, MS

Senior Clinician, Director LID Clinical Studies Unit
National Institute of Allergy and Infectious Diseases
Bethesda, Maryland, United States

Disclosure(s):

Luca Tudor Giurgea, MD: No financial relationships to disclose

Alison Han, MD, MS: No financial relationships to disclose

Lindsay Czajkowski, MSN, NP-C: No financial relationships to disclose

Holly Ann Baus, RN, MSN: No financial relationships to disclose

Gregory Mak, MD, MPH: No financial relationships to disclose

Kimberly Adao, RN, BSN: No financial relationships to disclose

Ian Bellayr, PhD: No financial relationships to disclose

Adriana Cervantes-Medina, BS: No financial relationships to disclose

Monica Gouzoulis, BS: No financial relationships to disclose

Jenna Sherry, MS: No financial relationships to disclose

Rani Athota, PhD: No financial relationships to disclose

Viviane Callier, PhD: No financial relationships to disclose

Sally Hunsberger, PhD: No financial relationships to disclose

Jaekeun Park, DVM, PhD: No financial relationships to disclose

Jeffery Taubenberger, MD, PhD: No financial relationships to disclose

Matthew J. Memoli, MD, MS: No financial relationships to disclose